Specificity of aminoglycoside antibiotics for the A-site of the decoding region of ribosomal RNA  by Wong, Chi-Huey et al.
Specificity of aminoglycoside antibiotics for the A-site of the 
decoding region of ribosomal RNA 
Research Paper 397 
Chi-Huey Wong, Martin Hendrix, E Scott Priestley and William A Greenberg 
Background: Aminoglycoside antibiotics bind to the A-site of the decoding 
region of 16s RNA in the bacterial ribosome. an interaction that is probably 
responsible for their activity. A detailed study of the specificity of aminoglycoside 
binding to A-site RNA would improve our understanding of their mechanism of 
antibiotic activity. 
Results: We have studied the binding specificity of several aminoglycosides 
with model RNA sequences derived from the 16s ribosomal A-site using surface 
plasmon resonance. The 4,5-linked (neomycin) class of aminoglycosides showed 
specificity for wild-type A-site sequences, but the 4,6-linked class (kanamycins 
and gentamicins), generally showed poor speclflcity for the same sequences. 
Methylation of a cytidine In the target RNA, as found in the Escherichia co/i 
ribosome, had negligible effects on aminoglycoslde binding. 
Conclusions: Although both 4,5- and 4,6-linked aminoglycosldes target the 
same ribosomal site, they appear to bind and effect antIbIotic activity in different 
manners. The aminoglycosides might recognize different RNA conformations or 
the interaction might involve different RNA tertiary structures that are not equally 
sampled in our ribosome-free model. These results imply that models of 
ribosomal RNA must be carefully designed if the data are expected to 
accurately reflect biological activity. 
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Introduction 
‘I‘hcrc is tremendous intercst in de\ eloping sni.ill mol- 
ccules that sclecti\.cly target RN.4 bccause of their poten- 
tial a5 therapeutic agents. Aminoglycosidcs [ 11 prn\.idc the 
hot current Ic;lcl structures because they hale cvolvcd to 
rccognizc spccitic sites v,ithin ribosomal RK.1 ]Z]. As a 
clxs. sminogl~cosidcs ha\2 lxxx known for fi\e decades 
:ind the antibacterial pruprrties of thousands of dcri\-ativcs 
ha~x been measured. :\t the moleculur IO cl. howc\xr. 
littlc is understood about the principles go\xrning amino- 
glycosiclc-RS.4 recognition. Only rcccntl!, beginning 
with the pioneering work of Sollcr’s group [3.1]. hale the 
propertics of aminoglycosides been ~inl7xig:itcd at the 
RN.A-binding Iexxl. 
B\ t:.lr the largest number of ;rminoglycosides fall in the 
class that binds tn the ;\-site of the ribosomal dec(~Jdilig 
region. ‘I‘hc function of the A-site during protcin sythcsi\ 
is to bind the charged aminowyl tRS.I corresponding to 
the next mRN,\ codon in ;I trsnscript. In 3 mcchanizm that 
h3s yet to bc clsrified. the decoding region hclpx to en5iIrc 
selection 01’ the correct cognate tRX:\. which is chosen 
with higher specificity than would bc cupected solcl~ from 
the three b3sc pair codon-arlticodori interaction. .\mino- 
glyosiclcs that bind to the decoding region (I.‘igurc 1) 
interfcrc with the ribosomal ‘proofrcadin~:’ mechanism. 
;rnd ktcl co miscoding tind/or prcmatilre termination. as 
\\ ell 2s inhibiting nascent polyl)eptidc rransloc;ition along 
the ribosomc. These xtiT.itia are Ixlic\ cd to be the GIIISC 
of the bactcricitlal action of thcsc antibiotics [Il. 
‘1%~ .\-site-binding aminoglycosidcs incllJtlc the -I..<- 
linked Z-dcos~streptalninc dcri\3tiws neomycin 1s. p:tro- 
mom!;cin and ribostam!cin. AS \\cll AS tho -l.h-linked 
kCinamycins And gentamicins. ‘l’he structlrr,lll! dissimilar 
:mtibiotic> h\gom\-tin R and aprnm\cin ~1x0 belong to 
the A-site-binding grump. One characteristic ot’ AI thcsc 
A-Gtc binders. in chemical footprinting expcrimcnts. is 
the strong protection of the G l-194 Si of the 1h.S riboso- 
mal RK,\. Otherwise. there ae notable differcnca vith 
rcspcct to other footprints. 3s well ;IS the obscrwd p;tt- 
terns of antibiotic rcsistxice. For cximple. mcthyl3tion of 
rhc (;l-l05 K7. \\ hich is found in the gcnc:imicin prodllcer 
strain .I/lonfnl/t/c/J;p~?i/ purpumf. confer5 resiwncc to the 
4.6-linked Z-dco~~streptamiric deriv,tivcs gentamicin 
:md kanamycin but not to ncom\cin D (a -I..5linked 
:lminogl\cosidc) [?I. 
The prcscnce of ribosomul prowin\ iz not ncccwr) for 
binding of sminoglycosidcs to the &coding region, 3 phc- 
nomcnon first dcmonstratcd by Purohit nncl Stern IS]. 
Tlq showed th;lt ;I 50-nuclcotide stem loop containing 
nucleotlclcs corresponding to both the .A-site and P-site of 
rhc dccoc1in.q region binds to neomycin B or pxomomycin 
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Structures of the aminoglycoside anlibiotics 
used in this study. (a) The 4,5-linked 
2-deoxystreptamine derivatives neomycin 6, 
paromomycin, ribostamycin, neamine, 
paromamine, and butirosin B. Note that both 
neamine and paromamlne are smaller two 
ringed structures, whereas ribostamycin is a 
larger structure. (b) The 4,6-linked 
P-deoxystreptamine derivatives kanamycin A 
and Et, tobramycin, and the gentamicins. 
(c) The structurally dissimilar aminoglycosides 
hygromycln B, apramycin, and streptomycin. 
with high affinity, giving rise to a protection pattern similar 
to that observed for 16s ribosomal RSA in the context of 
the entire ribosome [5]. Later it was shown that an even 
shorter RNA hairpin (AS-w), which corresponds to only 
bases of the A-site, contains an intact aminoglycoside- 
binding site [6,7]. Extensive mutational analysis has 
defined the nucleotides required for specific recognition of 
these antibiotics (Figure 2), which include a looped out 
nuclcotide 1492, adjacent to a G-C base pair [6]. In the 
position corresponding to base 149.5 in Esc/?eti&n cull 16s 
rRKA numbering either a uridine or a guanosine is required 
In order to close up the other side of the bulge a base pair is 
needed at position 1409-1491. 
The structure of paromomycin complexcd with the A-site 
model AS-w RYA has been determined recently using 
nuclear magnetic resonance (NXIK) spectroscojy [8]. I’aro- 
mom):cin sits in a pocket created by a bulged residue 
(A1492) and a non-canonical A14MLA1493 base pair (see 
Figure 2). The 2,0-diaminoglucosc ring stacks against the 
underside of the C1409-G1491 base pair, which forms the 
floor of the bulge created b); the looped-out adenosine 
residllc and the non-canonical .A14OH-1493 base pair. ‘I’he 
2-deoxvstrcptamine ring spans two base pairs in the major 
groove and its two amino groups make specific hydrogen- 
bond contacts with the N7 of Cl494 and the 06 of 111495. 
In addition, the N3 of the cyclitol ring and the hydroxyl 
groups of the glucosamine residue are involved in ionic- 
and/or hydrogen-bond interactions with the phosphates of 
.41493 and A1492 ‘I’he other two rings of the bound 
aminoglycosidc, the ribosc and idosc rings. arc dynamic in 
structure and do not appear to bc involved in any particular 
hydrogen bonds. 
Aminoglycosides have a general affinity for RNA because 
of their multiple positive charges. More important from a 
medicinal perspective, howcvcr, is their binding specificity 
- that is, their ability to discriminate between different 
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RNA sequences related to the ribosomal decoding region A-site, which 
IS shown in (a). The five sequences include (b) the wild-type A-site RNA 
(AS-wt), (c) a positive-control mutant that improves neomycin binding 
(AS-U1 406A), and three negative-control mutants: (d) AS-U1 495A. in 
which a noncanonical U-U base pair is replaced with U-A; (e) AS-res. 
in which a C-G base pair is replaced with a U-C base pair; and 
(f) AS-Ml 492, in which the bulged out Al 492 is deleted. 
I<S:\ structures. ‘rhe challenge of sequence- and struc- 
turc-specific recognition of a particular target site against 
the backdrop of a largely- homogeneous biopolymer is fun- 
damentally important to the field of molecular rccogni- 
tion. Even proteins often shobv only moderate specificity 
(I 100-fold versus nonspecific sequences) in the rccogni- 
tion of IiN/1 [9]. underscoring the difficulties that are 
likely to be encountered in the design of specific small 
molecules to target KSh. 
In addition to the interaction lvith their natural targets on 
the prokaryotic ribosome, aminoglycosides ha\:e been 
shown to bind a number of other different and diverse 
RKA sequcnccs. ‘l’hese include two mRN:\ scqucnces 
from I II\!. the Rev-responsive clement (RRE) [lo.1 11 and 
trtlns-activating response clcmcnt (‘l’i\R) [ 121. :1minogly- 
cosidcs can also inhibit catalytically acti\:c RN& such as 
the self-splicing grollp I introns 113,141 and the hammer- 
head ribozyme [1%.16]. Other RIiA sequences that bind to 
aminoglycosidcs have been derived using itz zho selection 
[ 17-211. In many of chew casts. hou;c\w, the spccificit) 
of the interactions remains unknov.n. which is primarily 
due to the scarcity of methods available to address this 
issue. Recently, we dc\:eloped a new method for directly 
obsctving aminoglycosidc-R-Y!\ interactions based on 
surface plasmon resonance (SPR) (221. I.:sing SI’R, wc ha\:e 
investigated the recognition of the h-sit-c of the ribosomal 
decoding region b\; aminoglycoside antibiotics. 
Results and discussion 
Specificity of paromomycin for A-site variants 
‘1’0 understand the specificity of ribosomal RSX tecogni- 
tion by the various aminoglyosidcs, WC decided to inves- 
tigatc their binding to the XS-wt scqucnce and compare 
these results with those from a series of control mIltants 
that have likclvisc been charactcrizcd using chemical 
footprinting (Figure 2). ‘I’hesc negative controls include 
the AS-Ii149.5;\, .WAA 1492 and AS-res RSAs. The 
mutations found in these RK;1s have been shown to abro- 
gate specific binding to paromomycin [61. In hS-1-1495i\ a 
critical hydrogen-bond acceptor that interacts with Sl of 
the 2-deoxytrcptamine ring has been rcmovcd, and the 
mutation A:11492 dcsttoys the bulged pocket in which 
patomomycin ring II (the glucose- ring) is positioned. 
Finally. in the AS-rcs mutant the G1491-(11409 base 
pair, which creates the floor of the binding pocket, is dis- 
ruptcd by replacing it with a C149-L!1409 mismatch 
base pair. Breaking up the critical G1491-Cl409 base 
pair in the E. CO/; 16s ribosomal RSA causes resistance to 
a broad range of aminoglycoside antibiotics [2]. In con- 
trast to these negative controls. the mutant hairpin /\S- 
111406.A contains all the necessary elements for specific 
aminoglycosidc recognition and binds paromomycin bvith 
wild-type specificity. 
\\:e utilized our tcccntly de\leloped SPR-based assay for 
quantitative measurement of binding of arninoglyzosides to 
these sequcnccs. Riotinylatcd derivatives of all scqucnces 
were prepared using in citrv transcription in the presence of 
guanosinc .j’-monophosphorothioatc followed by alkylation 
with a biotin iodoacctamidc derivative 1221. ‘I’hc RK,s1 con- 
jugatcs were then immobilized onto strcptavidin-coated 
SPR sensorchips for analysis. 
Figure 3 shows the results for binding of paromomycin to 
!\.S-wt. h clear 1:l binding isotherm is visible at low con- 
centrations. which is overlaid with nonspecific binding to 
additional equivalents at higher concentrations. ‘I’he 
pardmom~cin-XS-wt binding curve is in conttast with 
the curve obtained for the negative-control mutant 
.U-1!1493r\ (which binds patomomvcin 20-fold more 
weakly than AS-w) bccausc it dots not show formation of 
any discernible 1:l complex. 
Binding of aminoglycoside antibiotics to A-site variants 
In the same manner as described above for paromornycin. 
a panel of aminoglycosidcs \vas screened and the results 
are compiled in ‘I’able 1. Each dissociation constant was 
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Figure 3 
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compared with negative-control RNAs AS- 
U 1495A and RBE3 (a completely unrelated 
RNA hairpin). The K, value of paramomycin for 
AS-wt is 0.2 PM, for AS-U1 495A is 2.7 PM 
and for RBE3 is 3.2 FM. 
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determined from l-3 independent trials. In general, we 
have found that the SPR assay results ha1.e good rcpro- 
ducibilit): and, based on the observed \:ariation in multi- 
plc determinations, Eve estimate that all K, values arc 
accurate within a factor of three. Importantly, it should 
be noted that rclativc affinities of a given aminoglyoside 
for different RNA scquenccs arc very reliable, as the) 
arc detcrmincd simultancouslp in a single SPR experi- 
ment using the same solution of l&and. ;I11 data were 
rccordcd under near-physiological salt conditions (in 
HBS buffer: 1.50 rnA.1 N&l, IO mXI IIEPRS, 1111 7.4 and 
3 mM ElYl’A) unless noted otherwise. Although magnc- 
sium might be cxpectcd to influence aminoglycoside 
binding to RSI\. it is known that increasing the \‘lg2. 
concentration from 0 to 10 mM does not affect binding to 
these sequences [b]. Data points \vcrc taken at aminoglp- 
coside concentrations ranging from 0.01 to 100 UN. 
Below this conccnrration range, surface-transport limita- 
tions prevent the system from attaining equilibrium. 
Table 1 - -. _. ~. ._ 
Binding of aminoglycosides to variants of the ribosomal A-site 
decoding region. 
-.-.._ _ .-. - - _. -. _ 
Compound AS-wt U1406A U1495A AS-res Ml492 
~ -- - -. - -- -.- - 
Neomycin B 0.019 < 0.01 0.38 0.48 0.32 
Paromomycin 0.20 0.027 2.7 5.7 5.7 
Kanamycin B 1.4 4.4 4.0 3.5 2.7 
Tobramycin 1.5 2.1 4.1 7.9 4.5 
Gentamicin 1.7 9.9 12 18 16 
Apramycin 6.3 9.3 13 NA NA 
Ribostamycin 25 11 90 52 38 
Kanamycin A 18 28 33 37 32 
Neamine 7.8 5.5 31 NA NA 
Butirosin 27 1.8 99 NA NA 
Paromamine > 100 >lOO > 100 > 100 > 100 
Hygromycin B > 100 >lOO > 100 > 100 >lOO 
Streptomycin 94 66 74 NA NA 
.- - --- -. - 
All values are dissociation constants in units of PM. NA, not available. 
Except for the \:ery weakest binders, all of the aminogly- 
cosidcs analyr.ed have dissociation constants of less than 
100 /.~.ll for all the RSAs tested, including the negative 
controls. ‘The binding behavior, howcvcr, l:aried from 
compound to compound. A Scatchard analysis of the 
binding data showcd that the 4.5linked aminoglycosidcs 
form high-affinity 1:1 complexes with AS-w. and multiple 
equivalents bind only at higher relative concentrations of 
aminoglycoside. ‘The 4,6-linked aminoglycosidcs did not 
appear to form clear 1:l initial complexes. however. 
Rather, there appear to be multiple equivalents of amino- 
glycoside binding with similar affinity. Figure 4 illustrates 
the binding of paromomycin, a 4,Slinked aminoglpcoside. 
tobramycin and gentamicin from the 4,6-linked class, and 
Figure 4 
~. _.. ~ .- .- - 
I 
-. .- - 
4_-_--_- .-.- II 
x \ ;I 
I Equivalents bound Chcm~nlry & Bology 
-. ~ - - .-- J 
Scatchard analysis of binding to AS-w! by the 4,5-lmked 
aminoglycoside paromomycin, the 4,6-linked aminoglycosldes 
gentamicln and tobramycin and the core structure neamine. 
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Relationship between the number of amines (charge) in each 
amnoglycoside and their respective nonspecific binding affinity (K,) 
The number assigned for charge refers to the fully protonated state. 
Note that with each added charge. nonspecific affinity increases 
approximately tenfold. 
nearninc (the structure of which forms the basis of both 
the 4.5 and -I.&linked classes). Ncamine appears to have 
a second binding cvcnt at a slightly higher concentration 
than the initial 1:l complex, as its Scarchard plot is not 
absolutely lincar. 
‘I’he compounds in ‘l’able 1 are grouped according to the 
number of positi\:c charges at full protonation. DII~ to the 
low pK,, of some amino groups within the aminoglycosidcs 
(e.g., N3 of neomycin H has a pK, < 6) [23], the actual pro- 
tonation state at pll ‘7.4 will bc lower than expected. 
Loncthclcss. a clear trend can bc seen when examining 
the charge dcpcndence of aminoglycosidc binding to the 
ncgativc-control mutant R_\Tr\s, Xj-L11495X, AS-res and 
X!G-A,\1492 (Figure 5). 
DepcnLiing on the number of amines, nonspecific binding 
is in the 1, 10 or 100 pJI range for compounds with six, 
fi\:e or four amino groups, rcspecti\.ely. The general trend 
of an incrcasc in binding affinity by a factor of ten for 
cvcry atldcd charge also applies \vhen comparing com- 
pounds that bind specifically to the ;Vsitc (c.g.. paro- 
momycin and neomycin I<). ‘I’hesc results are consistent 
with rcccnt obsewations by \I’ang and Tor 1.241 in which 
synchctic aminoglycoside derivatives with additional 
charges wcrc more active in binding and inhibiting the 
hammcrhcnd riboxymc. 
‘l’hc affinities of the aminoglycosides for the three differ- 
cnt ncgativc controls showed little variation. Comparison 
of the binding data for .M-wt \vith these \.alues re\wls 
the recognition specificity of the aminog1yosides for the 
A-site sequence. ‘I‘he 4,.5-linked compounds with a 
Meoxvstreptamine core (neomycin U. paromom)-tin. 
ribostamycin) arc all specific for AS-w over the nega- 
tive-control RN.;\s. \\:ithin this group, four-ringed com- 
pounds show the tightest affinities and highest 
specificities, and binding to the positi\-e-control .G- 
I.‘l406.\ is also enhancctl. In contrast, the spccificit): of 
the .\S-I!14OhX mutant for ribostamycin is lower and 
binding is only \veaklp enhanced. Rutirosin. which is a 
trisaccharidc carrying a 4-amino-Z-h~drox):-~~~~t~ric acid 
substitucnt on Xl. likcwisc shows only modcrate speci- 
ficity for .\S-wt? but, unlike ribostamyin, binding to 
,\S-i!lLlOhr\ is significantly cnhanccd. 
‘I‘he 4,0-linked 2-deoxgtreptaminc dcrivati\.es (kana- 
mycin .-I, kanamyin B. tobramycin and gcntamicin) ha\-e 
only very moderate specificity for .:\S-\\:t. Furthermore, 
unlike the 45linked compounds, their binding affinit) 
to XS-I.1406A rclativc to hS-\vt is decreased. Roth 
groups of aminogtycosidcs considered hcrc, the 4.5 and 
4,6-linked Z-dcoxystrcptamine derivatives, are derived 
from the same core structure (bawd on nearnine), and 
share a common disaccharide motif. Seamine has 
increased nonspecific binding affinity compared to other 
compounds with foilr amines. I,ikc ribostamycin, 
neamine still retains moderate specificit\: for M-\vt over 
the negatiI.c-control r\S-Ir1495;\. Rcmo\.ing the h’-amino 
group of neaminc (paromamine) Icads to- a substantial 
dccrcasc in binding to XS-\\:t and a loss of spccif’icity for 
the /-\-site IiS.:\ sequence. 
;\pram);cin shows only marginal. if any, specificity for 
AS-\vc and h\:grom):cin H shows none. Both compounds 
arc knolvn to bc i\-site binders based on chcmicat foot- 
printing data. hut the): arc structurally dissimilar to the 
ncamine-containing group of antibiotics. Structurally. it is 
clear that neither apramycin nor hygromycin U can inter- 
act with AS-w in the same \{.a): as paromomycin. It is 
thcrcfore likely that M-w is not an appropriate scqucnce 
for examining binding of these two compounds to rihoso- 
mal RNA. ITinally. streptomycin, \j.hich binds a different 
region of the ribosome not involving the .-\-site, does not 
show any specificity for !\S-wt (as expected). 
‘l’ablc 2 shows a comparison of the binding specificities in 
the 4,5- and the 4.6-linked scrics. ‘I’he average K,, value 
for nonspecific binding was calculated from the binding 
constants to the negative controls XGL1495A. AS-res and 
.-\S-A-11492. 
For the neomycin scrics (i.c.. the 4,5linked 7-deoxystrcpt- 
amine dcri\:ativcs) the same order of spccificitics as seen for 
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Table 2 Table 3 
Specificity of recognition of AS-wt and AS-U1406A by various 
aminoglycosides. 
Compound 
Average 
K,(nonspeciftc) Specificity Specificity for 
(PM) for AS-wt U1406A 
Influence of pH and ionic strength on the specificity of RNA 
recognition. 
_ 
Specificity for 
Compound AS-wt AS-U 1495A AS-U 1495A -. .._ 
4,5-linked 
Neomycin B 0.39 20 >40 
Paromomycin 4.7 20 200 
Butirosin 99 4 60 
Neamine 31 4 6 
Ribostamycln 60 2 5 
4,6-linked 
Gentamicin 16 9 2 
Tobramycin 5.5 4 3 
Kanamycin B 3.4 2 -1 
Apramycin 13 2 1 
Kanamycin A 34 2 1 
Control 
Streptomycin 74 -1 1 
The K&nonspecific) was compared to both K&AS-wt) and 
K&AS-U 1406A) to derive the specificity values. 
Paromomycin 
HBS buffer alone 0.20 2.7 
+ 50 mM NH&Cl 0.29 6.5 
+ 150 mM NH&I 1.1 32 
pH 7.8 0.53 7.7 
Neomycin B 
HBS buffer alone 0.019 0.38 
+ 50 mM NH&I 0.025 1.1 
+ 150 mM NH& 0.15 6.7 
pH 7.6 0.044 0.91 
Values of dissociation constants are measured in PM. 
Effect of RNA methylation 
Although the chemical footprints on the intact ribosome 
for the 4.6-linked compounds overlap the footprints for 
neomycin H and paromomycin, the binding orientation 
of the molecule could well be diffcrcnt. as suggcstcd by 
the poor binding to the positive-control AS-IJ1406A 
mutant. An intriguing possibility is that the naturalI) 
occurring methylation on Cl407 might bc rcquircd for 
recognition hy these compounds. WC addressed this pos- 
sibility using A-site RLAs containing this modification. 
I?. co/i 16S ribosomal RNA contains several modified 
nuclcosidcs, among them three located within the 
decoding region. L”,Z’-O-dimcthytcytidinc 1402, 
5mcthylcytidine (m%) 1407, and 3-methyluridine 1498 
12.5-271. Of these. msC1407 is located within the amino- 
glycoside-binding domain of the A-site. Inspection of the 
SllR solution structure of paromomycin bound to AS-wt 
[8] rcvcals that the methyl substituent of m5C1407 
would be juxtaposed to the hydrophobic c1 face of the 
2,6-diamino-2,6-didcoxy-I.,-idosc ring of the aminoglyco- 
side. Dcpcnding on the prccisc atomic positions, this 
could be either a stabilizing hydrophobic interaction. due 
to exclusion of water from the interface, or a destabitiz- 
ing stcric clash. In addition, molecular modcting based 
on the NMR structure suggests that ring 3 of 4,6-linked 
aminogtycosides, such as gentamicin or tobramycin, 
could also contact the methyl substituent of mjC1407. It 
is atrcady known that this base modification does not 
advcrscly affect aminoglyosidc binding, as Noller and 
collcagucs’ footprinting data [3,4] was generated on 
whole ribosomcs containing msC1407, but the possibility 
that binding could be enhanced remained untcstcd. 
Rccausc our initial cnzymatically synthesized RNA 
oligonuclcotidcs (see above) contained cytidine rather 
than the natural m5C at position 1407, WC prcparcd 
scvcral chemically synthcsixcd RNA oligonuclcotidcs in 
order to study the effect of a j-methyl substituent at 
position 1407 on aminoglycoside binding. 
AS-wt is observed for the positive-control AS-U1406hz but 
the magnitude of the specificity is incrcascd. An cntircl) 
diffcrcnt situation is encountered with the 4,fFlinked scrics 
(kanamycins, tobramyin, gcntamicin) in which the 
observed specificities, with the cxccption of gcntamicin, 
are very moderate and practically no spccificit): is seen for 
the binding of thcsc compounds to the AS-I.‘1406A. 
Xtthough the amount of spcciticity varies for each amino- 
glycoside, in e\.ery case binding is worse for the AS-rcs 
mutant, which confers aminoglyoside resistance in 1<. m/i 
121, than for :2S-wt (Table 1). ‘[‘his observation underscores 
the need to target such mutations \vith new compounds to 
counter the emergence of aminoglycosidc-resistant bactcr- 
ial strains. \i’c would ultimately like to develop com- 
pounds that do not ha\:c specificity for AS-w over 
sequences such as AS-rcs. 
Influence of ionic strength and pH 
Both ionic strength and pII influence aminogtycoside 
binding, as shown in Table 3. Raising the pH from 7.4 to 
7.X has a modest cffcct of dccrcasing binding but, as 
judged from the ratio of K&AS-C1495A) to K&AS-w)? the 
specificity remains unchanged. Increasing the amount of 
competing ions by adding ammonium chloride likewise 
dccrcascs both the specific (.G-wt) and the nonspecific 
(AS-U1495A) binding to paromomycin or neomycin B. 
The effect is greater for nonspccitic binding, however. 
Thus, the specificity of both compounds for AS-w 
incrcascs at higher salt concentrations, an observation that 
agrees with the gcncral notion that charge<harge interac- 
tions arc the main, if not only. driving force for nonspecific 
RNA binding and that specific recognition involves addi- 
tional, nonionic contriblltions. 
14 
23 
26 
15 
20 
43 
43 
21 
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Figure 6 
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RNA seqences used in probing the influence of methylation of Cl 407. 
This base modification is found in E. co/i rlbosomal RNA, and potentially 
could affect aminoglycoside binding to the decoding region A-site. 
‘l’hc sequences of .i’-l~iotin~latctl oligoribonuclec~tides 
:\S-wt. XS-wt mX1407. containing the m”(:l407 substiw- 
tion, and 1’1495.A m~Wl407. containing the dclcrcrious 
1,‘1495,L\ mutarion along with the m”C1407 substitution. are 
shown in Figure 0. ‘l’hc oligoribonucleotides wcrc chcmi- 
tally synthesized Ilsing commercially available 5-methyl- 
.\:-‘-l~enzo)-l-.~‘-O-(dime~h~~x~trit):l)-~’-~-(~-b~~t~ldi~nct~~~lsil~ 
I)c~tidinc-3’-~\‘..~~-~~iiso~~rol~~l(c~anoeth~l) I)hosl)horamidicc, 
gel purified. and immobilized on 3 strcptavidin-coated 
SPR sensor chip surface . Aminoglyoside binding experi- 
ments in IIRS buffer at 25°C: or 37°C were performed 3s 
described abo~c. 
Figure 7 shows rcpresenlali\:e binding data and dcri\.cd 
isotherms for paromomycin and gentamicin binding to the 
various RKA scc~~~cnces. ‘I’hese data shop. that the 
m”C1107 substitution has littlc cffcct on cikr paro- 
momyin or gentamicin binding. The equilibrium dissoci- 
ation constants dcrivcd from a series of binding 
experiments \vith paromomyin, tobramycin. and gcntam- 
icin arc sho\vn in ‘I’able 4. For paromomycin, the KC, for 
AS-w mjC1407 is r\vofold less than AS-w, a diffcrencc 
that approaches the limit of accurate mcasurcmcnr. I;or 
both paromomycin and gentamicin, the K,, Aues for 
AS-w and AS-n;t m”C1407 arc identical. 
‘I‘hese rcslllcs suggest that thcrc is no interaction 
bctwccn the .Cmcthyl substitllcnt of mYI and the 
Figure 7 
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Semilogarithmlc plots of paromomycln and gentamicln binding to AS- 
wt, AS-wt mjC1407, and U1495A m5C1 407. 
aniinoglycoside antibiotics scudicd. (Icarlp. an unfa\or- 
able stcric clash can be ruled out. as this would bc 
expected to reduce bindin g affinity significantly for both 
the AS-w m%Z1407 and the 1’1405:I miC1407 scqucnccs. 
It is also clear that an optimi/.cd hydrophobic contact is 
not occurring. In the case of the -1,.Slinlted aminoglyco- 
sides. the SMR strucnlre indicates considcrablc confor- 
mational mobilit\: for the 2.6-diamino-2.G-dic~~(~x~i(~ose 
ring. ‘J‘hc conformation shown in the NMR strucnire. 
Lvhich juxraposcs rhc idosc ring wirh rhe methyl group. 
might not be the active conformation of the RIiA ;!I viw. 
If this conformation occurred only a small fraction of the 
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Table 4 be addrcsscd using this RS.A model system arc important ..__ 
Equilibrium dissociation constants (pM) for aminoglycoside 
for activity. This -is probably; also the case for the 4.6- 
binding to AS-w& AS-wt m5C1407, and U1495A m5C1407. linked compounds reported here, as they are clinically 
effecti1.c antibiotics despite the much lower affinity and 
Aminoglycoside AS-wt AS-wt m5C1 407 U1495Am%1407 spxificitv obsenled in the AS-w model system. 
Paromomycin 
Gentamicin 
Tobramvcin’ 
0.18 0.38 3.0 
0.61 0.50 5.9 
, 1 .o 1.2 5.0 
time, the effects of any potential interaction would be 
amclioratcd. In the case of the 4,6-linked aminoglyco- 
sides. it is possible that ring 3 dots not actually contact 
mSC1407. Because there is no structural data available in 
this case, the possibility cannot be rlllcd out. 
To evaluate the validit): of the binding data obtained 
through SI’R, it is instructive to compare the results 
obtained hcrc with binding constants obtained using other 
cxpcrimcntal tcchniqucs. Puglisi and coworkers [6] have 
determined the dissociation conscant of the paro- 
momycin-AS-\vt complex at 0.2 pAI using quantitati1.e 
chemical footprinting. Their value is in excellent agree- 
mcnt with the dissociation constant obtained using SPK 
(0.2 PSI). \Yorking w;ith a slightly cxtcndcd RNA hairpin 
containing the same wild-type sequence. Purohit and stern 
[5] obtained RXase footprints that suggest a binding con- 
stant of -0.1 p\l for neomycin 13, compared with 0.02 @I 
determined using our assay. Lsing a competition fluores- 
ccncc assay, Rando and coworkers [28] determined dissoci- 
ation constants with a longer RN,\ hairpin containing the 
h-site. These workers obtained K, values for paromomycin 
(1 .c) pAI), neomycin R (0.13 ,@I). gcntamicin (1.8 pJl), 
kanamycin R (2.1 FJI) and tobramycin (1.7 /.&I) I%]. Thus, 
the same tenfold difference in binding affinity between 
paromomycin and neomycin H is observed by these 
authors? and the differences in the determined I(,, values 
versus the SPR assay is within an o&r of magnitude for all 
compounds. Similar affinities have also been obtained 
when studying ribosomal binding, rather than the binding 
of isolated RNA. Both kanamycin [29] and tobramycin [30] 
bind to intact ribosomes with an affinity of 1-lO/_~h,t as 
determined by equilibrium dialysis [Xl]. There is, there- 
fort, good qualitative and quantitative agrccmcnt of the 
binding data obtained using SPR with previously dctcr- 
mined RKA-binding data. Compared to gel-based assays, 
the SPK assay is quicker. generally more reliable for small- 
molecule-RKA interactions [ZZ]. and allows determination 
of binding stoichiomctry. 
Rcccntly wc rcportcd on the A-site binding and antibactc- 
rial acrivit?; of a number of synthetic dcrivativcs of 
neomycin and some of the natural 4,.5-linked aminoglyco- 
sides 1321. A synthetic derivative with lower binding affin- 
ity and specificity than neomycin had cquivalcnt 
antibacterial activity, suggesting that Factors that cannot 
Also very rcccntl\:, Puglisi and colvorkcrs [X3] reported 
S\IR and chemical-modification studies of the 4,5-linked 
aminoglycosidcs neomycin, paromomycin, and ribosta- 
mycin, as well as ncamine. ‘I’heir studies suggest that this 
class binds X-site RKA specifically, and with similar struc- 
tures. These results are consistent with those WC: have 
obtained using SPR. A correlation bctwccn our \;er)- dif- 
fcrcnt data on the 4,6-linked aminoglycosidcs and struc- 
tural characterization of a complex of one of these 
compounds w:ith .A-site RKA remains to bc dctcrmincd. 
\I:e belie\:e that the results prcscntcd here reflect the fact 
that protein-free ribosomal RNA model systems arc taken 
out of their ribosomal context. As SIIC~ they lack gcomct- 
ric constraints imposed by the ribosomal surroundings, 
rvhich might. or might not affect ligand binding. Clearly, 
AS-wt is a good model system for studying the interaction 
between the ribosomal A-site with the 4,i-linked amino- 
glycosides. In this regard it is likely that the positive 
control mutant AS-I 114OOA approximates the conforma- 
tion of the bound ribosomal complex cvcn bcttcr than 
AS-wt and is therefore the preferred model for developing 
structure-activity relationships for thcsc aminoglycosidcs. 
On the other hand? AS-wt appears to be a less accurate 
model for the binding behavior of the other major class of 
clinically important aminoglycosidcs, namely the 4,Minked 
trisaccharides kanamycin A, kanamycin H, tobramycin and 
gentamicin. ‘I’his could bc due to the fact that the 
4,6-linked class recognizes a diffcrcnt conformation of the 
same RSA scqucncc that is not well rcprescnted in the 
AS-wt model, or because tertiary interactions with other 
parts of the ribosomc arc important for binding by this class 
of antibiotics. Both classes of aminoglycosidcs bound with 
lower relative affinity to AS-rcs, a scqucncc dcrivcd from 
aminoglycosidc-resistant E. m/i. Such mucdnt sequences 
are an important target for design of new antibiotics to 
combat resistant bacteria. 
Cart must be taken in the sclcction of the proper ;n vitro 
KKA model system, as seen from the results for the A-site 
models. The available structural evidence from Nh:IR sug- 
gcsts that short RNA hairpins arc quite disordcrcd in the 
abscncc of a bound ligand. ‘I-his dynamic behavior will 
impost energetic penalties that could obscure binding 
cvcnts of moderate specificity. In the case of ribonucleo- 
protein complcxcs such as the ribosomc, protein-free 
mod& that appear to bind ligands similarly to the parent 
system (by chemical footprinting) might not accurately 
reflect the Nz GZYJ binding cvcnt. Although it is bclicvcd 
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that alninogl~cosidcs solcl\; contact KS.4 in the ribosornc. 
and not protein. it is likely that local I<Yij.:\-protein tcrtiar) 
intcr:lctions affect ligand binding and vice \xrsa. \Yith this 
in mind. wc: bclievc that binding of aminoglyosides to 
their ribosomal target sites Ivill probably not follow ;1 
simple ‘competiti\.e inhibition’ paradigm. Rather. a bound 
aminoglycosidc molcclk allostcrically intcrfercs with 
jxotcin s\-nthesis by lowcrin g the selectivity of cognate 
versus noncogrxltc aminoacyl-tRSA sclcction. ~1s has been 
suggcstcd for streptomycin 3rd neomycin [.341. Conccptu- 
ally, this is more akin to n receptor signaling went. where a 
bound ligancl irrcspecti\x of its affinity ma): either beha1.c 
as an agonist or an antagonist. It is not at all clear whether 
increased affinit)- of ;I liginti for the ribosomal A-sitr. \voLlld 
translate intu better potcncp as an antibacterial drug, 
which is especially noteworthy when considering that the 
ribosome is present at micron&r concentrations in the cell. 
Significance 
Although aminoglycoside antibiotics have been in USC for 
over 50 years, only recently have we begun to under- 
stand their mechanism of action on a molecular level. 
\!!e have used surface plasmon resonance (SW) to 
study the interactions of a number of structurally diverse 
aminoglycoside antibiotics with RNAs that model the l?. 
coli ribosomal decoding region A-& RNA. SPli allows 
rapid quantitative determination of the binding constant 
and stoichiomehy, and is more reliable than gel assays 
for studying small-molecule-snlall-1~~~~ interactions. 
Specificity for the wild-type sequence over closely related 
variants was observed for the 4,Slinkcd 2-deosystrepta- 
mine derivatives that comprise the neomycin class of 
aminoglycosides. The 4,6-linked derivatives of the 
kanamycin/gentamicin class, and other structurally dis- 
similar aminoglycosides, that have been footprintcd to 
the same ribosomal-binding site, had different, and 
weaker, specificity profiles toward these RNA 
sequences. The results suggest that the two aminoglyco- 
side classes bind the A-site in different manners, possihl! 
involving tertiary interactions that cannot he accounted 
for in this ribosome-free model system. They may effect 
their antibiotic activity through subtly different changes 
to the conformation and dynamics of the ribosomal A- 
site. The results imply that care must he taken in dcsign- 
ing in vitro model systems for studying 
RNA-small-molecule interactions if results are cxpectcd 
to accurately reflect biological activity. 
Materials and methods 
Neomycin B sulfate (Fluka) was converted to the free base by passing 
it through Amberlite IRA 400 (OH- form) and purified by ion exchange 
chromatography on Dowex l-X2 100; the purity of neomycin B was 
verified by NMR in D,O. Neaminc was obtained by acid-catalyzed 
cleavage of neomycin 6 and purified by ion exchange chromatography 
on Amberlite CG-50. Paromaminc was obtained by acid-catalyzed 
cleavage of paromomycln and purified in the same manner. Paro- 
momycin sulfate, ribostamycln sulfate. kanamycin A sulfate, kanamycin 
B sulfate, butirosin sulfate and streptomycin sulfate were obtained from 
Sigma and used as received. Tobramycm. gentamicin sulfate (gcntam- 
lcin C complex containing a mlxture of the structures shown in 
Figure 1). apramycin sulfate. and hygromycin 6 hydrochloride were 
obtained from Fluka and used as received. 
RNA Synthesis 
Enzymatically synthesized 5-blotinylated RNAs were prepared as previ- 
ously described [22]. Synthetic RNAs containing the rn% modification 
were prepared as follows. V-phenoxyacetyl-5’.0-(dimethoxytrityl)-2’.O- 
(t-butyldlmethylsilyI)-adenosine-3’-N,di~sopropyl(cyanoethyl) phospho- 
ramidite, N2-isopropylphenoxyacetyl-5’-O-(dimetho~~ityl)-Z’-~(~-butyl- 
dimethylsilyl)guanosine-3’-N,N-diIsopropyl-(cyanoethyl) phosphoramldde, 
N~-acetyl-5’-O-(dimethoxytrityl)-2’-O-(t-butyldimcthyl-silyl)cyt~dine-3’-N,N- 
diIsopropyl(cyanoethyl) phosphoramiditc. 5’.0-(dimethoxytrityl)-2’-O-(t- 
butyldimethylsllyl)uridIne-3’-N,N-diisopropyl(cyanoethyl) phosphramidite, 
and cytidine-derivatlzed polystyrene support were purchased from Phar- 
macia. 5-methyl-N4-benzoyl-5’-Q(dlmethoxytr~tyl)-2’-O-(t-butyldimethylsi- 
lyl)cytidine-3’.N,N-dilsopropyl(cyanoethyl) phosphoramldite was pur- 
chased from Chemgenes and 5’.biotin phosphoramidite was purchased 
from Glen Research. All phosphoramldites were used as 0.1 M solutions 
in anhydrous acetonitrile. Oligonbonucleotides were synthesized on a 
Pharmacla Gene Assembler Special using 0.25 M 5-ethylthio-1 H-tetra- 
zole as the activator and 5 min coupling tlmcs for all phosphoramidltes 
[341. After synthesis, the solid supports were vacuum dried and treated 
with ammonia saturated ethanol for 18 h. The supernatants were 
removed, divided into four equal aliquots, and lyophilized. These aliquots 
were then each treated with 250 pl of dcprotection solution (0.75 ml 
N-methylpyrollidlnone). 375 ml triethylamine. and 0.5 ml triethy- 
lamineo3HF) and incubated for 1.5 h at 65°C. The dcprotected oltgos 
were precipitated by addition of 25 pl 3M sodium acetate. followed by 
1 ml n-butanol. After centnfuging for 15 mln at 14,000 rpm. the supcr- 
natant was removed, and the pellet was washed twice with 70% ethanol 
and vacuum dried. The crude ollgonucleotides were purified by elec- 
trophoresis on denaturing 20% polyacrylamide gels. recovered by the 
‘crush and soak’ method, and desalted on NAP-10 size exclusion 
columns (Pharmacia) in 1 mM Tris, pH 7.5, 0.1 mM EDTA. The resulting 
oligonucleotlde solutions were stored at -20°C. 
Binding experiments 
Binding experiments were performed on a BlAcore 2000 Instrument 
essentially as previously described [22]. Sensor chips SA (BIAcorc AB) 
were preconditioned by washing with three 1 min pulses of 1 M NaCI. 
50 mM NaOH at lOpl/m~n. 0.1 FM RNA solutions were renatured by 
heating to 85°C and slowly cooling to ambient temperature. The solu- 
tions were adjusted to 1 M NaCI, 0.5X HBS before lmmobllizing on the 
sensorchlp at a flow rate of 10 @/min for 5 min. Amlnoglycoslde 
samples were prepared by serial dilutions from stock solutions in RNase 
free microfuge tubes (Ambion) and were centrifuged at 14000 rpm for 
degassing. Unless otherwise noted. all binding studies were carried out 
using HBS buffer (Pharmacia Biosensor AB) which was used as 
obtained. All procedures for bindmg studies were automated as 
methods using repetitive cycles of sample Injection and regeneration. 
Typically. buffer was injected In the first two cycles to establish a stable 
baseline value. Samples were injected at a flowrate of 5-l 0 ul/min 
using the KINJECT command. To mlnlmize carry over! samples were 
Injected in order of increaslng concentration. Each data point was cot- 
rected for long term Instrument drift by comparison of baseline values in 
an unfunctionalizcd reference flow cell with the origlnal value prior to the 
experiment. Expected values for the equilibrium response of one equiva- 
lent of analyte were calculated from the relative molecular weight of the 
analyte and the immobilized RNA ligand in each flowcells and adjusted 
with a correction factor of 0.76 which arises from the different molar 
refractive Indices of RNA and the analyte. Binding constants were calcu- 
lated by fitting the data (equivalents of amlnoglycoslde bound vs. amino- 
glycoside concentration) to a model with n independent constants using 
the fitting program provided in the program Kaleidagraph (Macintosh). 
Data from two independent experiments were averaged to obtain the 
reported dissociation constants. 
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